Sep 7, 2017

Toys "R" Us might opt for bankruptcy

AP Photo/Carolyn Kaster

Toys "R" Us has hired law firm Kirkland & Ellis to work through debt restructuring options that could possibly include a bankruptcy filing, according to multiple media reports. This comes just a couple of months after the specialty retailer disclosed that it had retained Lazard to work on its balance sheet, which includes around $5.05 billion of long-term debt ($400m of which comes due next year). Toys "R" Us is owned by private equity firms Bain Capital and KKR, which took the company private in 2005 for around $6.6 billion (not including debt assumption).

Why it matters: An under-reported story from the financial crisis was the relative paucity of large leveraged buyouts that went bust, despite the glut of overpriced take-privates that occurred between 2005 and 2008. But Toys "R" Us might serve as a contradictory coda.

Flashback: I interviewed Toys "R" Us CEO Dave Brandon — who has past experience leading PE-backed companies, such as Domino's — at a Fortune conference in July 2016, and asked if the original buyout was a mistake (video here, skip to 14:40). His reply, in part: "

I don't think I'm in a real good mood to talk about mistakes my bosses made.... I'm sure they had growth prospects in mind that were steeper than what we've experienced. Typically private equity funds do not want to carry investments for 10, 11, 12 years, so I think it's safe to say that the time horizon of this investment from an IRR standpoint has stretched beyond their original plan."

Go deeper

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 3 a.m. ET: 665,164 — Total deaths: 30,852 — Total recoveries: 140,225.
  2. U.S.: Leads the world in cases. Total confirmed cases as of 3 a.m. ET: 124,665 — Total deaths: 2,191 — Total recoveries: 1,095.
  3. Federal government latest: President Trump announces new travel advisories for New York, New Jersey and Connecticut, but rules out quarantine enforcement. Per the CDC, residents of those states must now "refrain from non-essential domestic travel for 14 days," with the exception of critical infrastructure industry workers.
  4. State updates: Alaska is latest state to issue a stay-at-home order — New York is trying to nearly triple its hospital capacity in less than a month and has moved its presidential primary to June 23. Some Midwestern swing voters who backed Trump's handling of the virus less than two weeks ago are balking at his call for the U.S. to be "opened up" by Easter.
  5. World updates: In Spain, over 1,400 people were confirmed dead between Thursday to Saturday.
  6. 🚀 Space updates: OneWeb filed for bankruptcy amid the novel coronavirus pandemic.
  7. Hollywood: Tom Hanks and Rita Wilson have returned to U.S. after being treated for coronavirus.
  8. What should I do? Answers about the virus from Axios expertsWhat to know about social distancingQ&A: Minimizing your coronavirus risk
  9. Other resources: CDC on how to avoid the virus, what to do if you get it.

Subscribe to Mike Allen's Axios AM to follow our coronavirus coverage each morning from your inbox.

Coronavirus updates: Global death toll tops 30,000

Data: The Center for Systems Science and Engineering at Johns Hopkins, the CDC, and China's Health Ministry. Note: China numbers are for the mainland only and U.S. numbers include repatriated citizens and confirmed plus presumptive cases from the CDC

The novel coronavirus has now killed more than 30,000 people around the world — with Italy reporting over 10,000 deaths, per Johns Hopkins data.

The big picture: The number of deaths from COVID-19 in the U.S. surpassed 2,000 on Saturday. The United States leads the world in confirmed coronavirus infections — more than 124,000 by early Sunday. The number of those recovered from the virus in the U.S. passed the 1,000-mark on Saturday evening.

Go deeperArrowUpdated 5 mins ago - Health

Gilead expands access to experimental coronavirus drug in emergency cases

Photo: Olivier Douliery/AFP via Getty Images

Gilead Sciences CEO Daniel O’Day said in an open letter Saturday the company is expanding access to its experimental anti-coronavirus drug remdesivir to include severely ill COVID-19 patients.

The big pig picture: President Trump has called the antiviral drug "promising," but the results of six clinical trials on this investigational medicine are still being conducted, so its effectiveness in COVID-19 the treatment has yet to be proved. The World Health Organization is involved in the tests.

Go deeperArrow28 mins ago - Health